For informational purposes only — not investment advice

← Back to signals

LIN

LONGINSIDER BUYCONGRESS SELL

LINDE PLC

Research: Finviz ↗·Perplexity ↗

Funds
4
Score
5.13
vs SPY
-9.4%
Stock return (since Q-end)
-7.3%
SPY return (since Q-end)
+2.1%
Current price
$481.29
Days to cover (short int.)
2.6d-14.4%
as of 2026-07-31

News Summary

Neutral

Linde delivered Q2 earnings beats (EPS +11% YoY) and secured a record $8.1B gas backlog including a major $1B semiconductor deal, but the stock fell 5.9% due to management raising capex guidance by 9.5% while earnings guidance advanced only 0.3%, signaling margin pressure ahead. The company faces headwinds in its U.S. homecare business from cost inflation and policy changes, partially offset by strong renewable energy expansion and semiconductor growth tailwinds.

Red flags

  • Capex growth (9.5%) significantly outpacing earnings growth (0.3%), suggesting diminishing returns on capital investment
  • Margin compression in U.S. homecare business with ongoing remediation or possible divestment under evaluation
  • Market repriced stock down $14B despite earnings beat, indicating investor skepticism about forward capex efficiency

Funds Buying (4)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Lone Pine CapitalSteve Mandel1.6M+1.6M$809M4.9%NEW
D1 CapitalDan Sundheim342K+342K$177M0.5%NEW
Soros Fund ManagementSoros Family Office267K+7K$139M1.8%+3%Existing
Point72Steve Cohen48K+48K$25M<0.1%NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where LIN ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Lone Pine Capital

position #7 of this fund's book

  1. 4HOME DEPOT INC$918M
  2. 5APPLIED MATLS INC$873M
  3. 6MEDLINE INC$827M
  4. 7LINDE PLC$809M
  5. 8TERADYNE INC$722M
  6. 9CORNING INC$697M
  7. 10CARVANA CO$692M
Soros Fund Management

position #11 of this fund's book

  1. 8PG&E CORP$180M
  2. 9RIVIAN AUTOMOTIVE INC$156M
  3. 10APPLE INC$153M
  4. 11LINDE PLC$139M
  5. 12LUMENTUM HLDGS INC$119M
  6. 13TKO GROUP HOLDINGS INC$116M
  7. 14SUPER MICRO COMPUTER INC$111M
D1 Capital

position #31 of this fund's book

  1. 28MARTIN MARIETTA MATLS INC$199M
  2. 29COMPASS INC$188M
  3. 30COUPANG INC$179M
  4. 31LINDE PLC$177M
  5. 32TESLA INC$169M
  6. 33LATTICE SEMICONDUCTOR CORP$166M
  7. 34SEA LTD$161M

Values are quarter-end position sizes. Shown only for funds where LIN ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Signal History

QuarterDirectionFundsScorevs SPY
Q2 2026LONG45.13-9.4%
Q1 2026LONG45.50-22.0%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Reynolds Paula RosputBUY100$479.12$0.05M2026-08-18

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G34.9M7.5%2026-04-30

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan ArmstrongsenateSELL$15,001 - $50,0002026-03-272026-07-21

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.